Resistant prostate cancer male castration. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Prostate Cell Line, Tumor Tumor Cells, Cultured Seminal Vesicles Epithelial Cells Testis Neoplastic Stem Cells Chromosomes, Human, Pair 8 Epididymis Stromal Cells Cell Nucleus Cell Line Rectum Neoplastic Cells, Circulating Urogenital System

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic Mice, Inbred C57BL

Diseases31

Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Neoplasms, Hormone-Dependent Prostatic Hyperplasia Adenocarcinoma Neoplasm Metastasis Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Carcinoma Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasm Recurrence, Local Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Disease Models, Animal Pancreatic Neoplasms Prostatitis Neovascularization, Pathologic Urinary Bladder Neoplasms Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Neoplastic Cells, Circulating

Chemicals and Drugs76

Androgen Antagonists Receptors, Androgen Taxoids Prostate-Specific Antigen Androgens Testosterone Dihydrotestosterone Tosyl Compounds Tumor Markers, Biological Flutamide Androgen Receptor Antagonists Antineoplastic Agents, Hormonal Anilides Antineoplastic Agents RNA, Messenger Finasteride Neoplasm Proteins 5-alpha Reductase Inhibitors Azasteroids Metribolone RNA, Small Interfering Gonadotropin-Releasing Hormone Leuprolide Nitriles Androstenols Anticarcinogenic Agents Phenylthiohydantoin Cancer Vaccines 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Glutamate Carboxypeptidase II Cyproterone DNA, Neoplasm Estradiol Antineoplastic Agents, Phytogenic PTEN Phosphohydrolase Goserelin Androgen-Binding Protein Testosterone Congeners Gonadal Steroid Hormones Antigens, Neoplasm Clonixin Proto-Oncogene Proteins c-akt Prostatic Secretory Proteins Tumor Suppressor Protein p53 Proto-Oncogene Proteins c-bcl-2 RNA, Neoplasm Transcription Factors Estrogens Receptors, Estrogen Racemases and Epimerases DNA-Binding Proteins MicroRNAs Androstane-3,17-diol Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase Estramustine Receptor, erbB-2 Clusterin Proto-Oncogene Proteins Enzyme Inhibitors Antibodies, Monoclonal Glutathione S-Transferase pi Cyproterone Acetate DNA Primers Ki-67 Antigen Paclitaxel Drug Implants Butorphanol Testosterone Propionate Kallikreins Luteinizing Hormone Haptoglobins Hormones Steroid 17-alpha-Hydroxylase Diethylstilbestrol Oncogene Proteins, Fusion

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Orchiectomy Castration Prostatectomy Early Detection of Cancer Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Neoplasm Grading Neoplasm Staging Neoplasm Transplantation Prognosis Transplantation, Heterologous Immunohistochemistry Blotting, Western Risk Factors Digital Rectal Examination Gene Expression Profiling Case-Control Studies Follow-Up Studies Transurethral Resection of Prostate Risk Prospective Studies Survival Analysis Retrospective Studies Treatment Outcome Biopsy Survival Rate Sensitivity and Specificity Risk Assessment Combined Modality Therapy Transfection Biopsy, Needle Odds Ratio Incidence Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Disease-Free Survival Brachytherapy Cohort Studies Tumor Burden Organ Size Tissue Array Analysis Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Disease Models, Animal Drug Screening Assays, Antitumor SEER Program Multivariate Analysis Predictive Value of Tests Registries Radiotherapy Models, Biological Molecular Targeted Therapy Logistic Models Flow Cytometry Reproducibility of Results Nomograms Radiotherapy Dosage Radiotherapy, Conformal Immunoenzyme Techniques Questionnaires Gene Knockdown Techniques Mass Screening Clinical Trials as Topic Confidence Intervals In Situ Hybridization, Fluorescence Random Allocation Radiotherapy, Intensity-Modulated Ovariectomy Drug Administration Schedule Radiotherapy Planning, Computer-Assisted Anesthesia, Local Real-Time Polymerase Chain Reaction

Psychiatry and Psychology2

Anxiety, Castration Smoking

Phenomena and Processes47

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Genetic Predisposition to Disease Signal Transduction Time Factors Cell Division Cell Survival Down-Regulation Risk Genotype Cell Growth Processes Mutation Sensitivity and Specificity Dose-Response Relationship, Drug Up-Regulation Transfection Odds Ratio Promoter Regions, Genetic Cell Movement Base Sequence DNA Methylation Cell Cycle Organ Size Polymorphism, Genetic Gene Expression Gene Silencing RNA Interference Nomograms Gene Fusion Drug Resistance Genes, Tumor Suppressor Diet Chromosomes, Human, Pair 8 Phosphorylation Transcription, Genetic Phenotype Alleles Drug Synergism Polymorphism, Single Nucleotide Genes, Neoplasm Amino Acid Sequence Germ-Line Mutation Protein Binding Radiation Tolerance Drug Resistance, Microbial

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Animal Welfare Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Molecular Sequence Data Base Sequence SEER Program Registries Radiotherapy, Conformal Questionnaires Radiotherapy, Intensity-Modulated Amino Acid Sequence Radiotherapy Planning, Computer-Assisted

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care31

Risk Factors Watchful Waiting Case-Control Studies Follow-Up Studies Risk Prospective Studies Survival Analysis Retrospective Studies Treatment Outcome Survival Rate Sensitivity and Specificity Risk Assessment Odds Ratio Incidence Disease-Free Survival Age Factors Cohort Studies Kaplan-Meier Estimate National Cancer Institute (U.S.)SEER Program Multivariate Analysis Predictive Value of Tests Registries Logistic Models Reproducibility of Results Nomograms Questionnaires Mass Screening Clinical Trials as Topic Confidence Intervals Random Allocation

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Orchiectomy Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Castration Androgen Antagonists Receptors, Androgen Prostate Taxoids Cell Line, Tumor Drug Resistance, Neoplasm Prostate-Specific Antigen Androgens Testosterone Prostatectomy Neoplasms, Hormone-Dependent Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Dihydrotestosterone Tosyl Compounds Mice, Nude Adenocarcinoma Neoplasm Metastasis Early Detection of Cancer Disease Progression Tumor Markers, Biological Flutamide Androgen Receptor Antagonists Apoptosis Prostatic Intraepithelial Neoplasia Antineoplastic Agents, Hormonal Anilides Bone Neoplasms Antineoplastic Agents Cell Proliferation Tumor Cells, Cultured Seminal Vesicles RNA, Messenger Neoplasm Invasiveness Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Finasteride Neoplasm Grading Neoplasm Proteins Neoplasm Staging Neoplasm Transplantation Genetic Predisposition to Disease Prognosis Transplantation, Heterologous Immunohistochemistry 5-alpha Reductase Inhibitors Blotting, Western Risk Factors Digital Rectal Examination Breast Neoplasms Watchful Waiting Gene Expression Profiling Signal Transduction Time Factors Carcinoma Cell Division Neoplasms Azasteroids Cell Survival Case-Control Studies Down-Regulation Mice, SCID Lung Neoplasms Follow-Up Studies Metribolone Transurethral Resection of Prostate Risk Prospective Studies Genotype RNA, Small Interfering Survival Analysis Gonadotropin-Releasing Hormone Cell Growth Processes Ovarian Neoplasms Leuprolide Retrospective Studies Neoplasm Recurrence, Local Treatment Outcome Nitriles Mutation Androstenols Biopsy Survival Rate Sensitivity and Specificity Risk Assessment Anticarcinogenic Agents Phenylthiohydantoin Combined Modality Therapy United States Dose-Response Relationship, Drug Cancer Vaccines Colonic Neoplasms 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Glutamate Carboxypeptidase II Up-Regulation Cyproterone

No FAQ available that match "resistant prostate cancer male castration"